Hjem › Graft-versus-host-sygdom › Florida
Graft-versus-host-sygdom kliniske forsøg i Florida
7 studier for Graft-versus-host-sygdom søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- University of Miami, Miami
RekruttererFase 1/2
Alder 18 til 120 · Alle køn · Opdateret 28. sep. 2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06910969Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT06450925Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07216443A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Miami, Miami
RekruttererFase 2
Alder 2 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT06615050A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.